Emergent BioSolutions Inc (NYSE:EBS)

48.17
Delayed Data
As of Feb 23
 -1.22 / -2.47%
Today’s Change
27.94
Today|||52-Week Range
51.25
+3.66%
Year-to-Date

Today’s Trading

Previous close49.39
Today’s open50.34
Day’s range46.49 - 50.34
Volume615,766
Average volume (3 months)393,346
Market cap$2.4B
Data as of 4:02pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+51.33%
Earnings growth (this year)+23.25%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+14.75%
P/E ratio28.3
Price/Sales4.17
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.70+2.29%
INVAInnoviva Inc-0.11-0.68%
MYOKMyoKardia Inc-0.50-0.87%
LXRXLexicon Pharmaceutic...-0.58-6.55%
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 4, 2018
EPS forecast (this quarter)$0.29
Annual revenue (last year)$560.9M
Annual profit (last year)$82.6M
Net profit margin14.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
Executive VP-
Business Operations
Adam R. Havey
Corporate headquarters
Gaithersburg, Maryland

Forecasts